Related Experiment Video

Updated: May 13, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Prospective risk analysis of the anti-infective medication administration process

Ana Elisa Bauer de Camargo Silva1, Silvia Helena De Bortoli Cassiani

  • 1Faculdade de Enfermagem, Universidade Federal de Goiás, Brazil. anaelisa@terra.com.br

Revista Latino-Americana De Enfermagem
|March 6, 2013
PubMed
Abstract

Insights

This study used Failure Mode and Effect Analysis (FMEA) to identify risks in intravenous anti-infective medication administration. Proactive, low-cost interventions significantly reduced potential patient safety incidents.

Area of Science:

  • Healthcare quality improvement
  • Patient safety research
  • Clinical risk management

Background:

  • Medication administration errors pose significant risks to patient safety.
  • Proactive risk assessment is crucial for preventing adverse events in healthcare settings.

Purpose of the Study:

  • To analyze potential risks in the intravenous anti-infective medication administration process.
  • To identify failure modes, effects, and causes within the process.
  • To recommend interventions for enhancing medication administration safety.

Main Methods:

  • An exploratory study utilizing Failure Mode and Effect Analysis (FMEA).
  • Data collected through 24 meetings (56 hours) with a multidisciplinary team (doctor, nurse, technician, pharmacist, risk manager).
  • Analysis performed using Microsoft Excel and Xfmea4 software.

Main Results:

  • Identified 52 failure modes, 79 effects, and 285 causes related to organizational, human resource, and physical/material factors.
  • Recommended 298 improvement actions for high/average priority causes; 81.9% were short-term.
  • Simulated interventions showed a 79.7% reduction in high-priority failure modes.

Conclusions:

  • The study successfully identified patient risks and proposed rapid, low-cost interventions.
  • Recommended actions positively impacted risk reduction, enhancing medication administration reliability and safety.
  • Nurses play a key role in preventing medication incidents through risk analysis methods.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...